RNA interference (RNAi) is a gene silencing mechanism that can be triggered by introducing double-stranded RNA (dsRNA) into cells expressing the appropriate molecular machinery, which then degrades the corresponding endogenous mRNA. RNAi can be used for determining gene function and creating functional 'knockout' organisms. Here we show for the first time that RNAi can be induced in adult fruit flies by injecting dsRNA into the abdomen of anesthetized Drosophila, and that this method can also target genes expressed in the central nervous system (CNS). Two genes were targeted to investigate the effects of dsRNA injection on their mRNA content; lacZ transgene (expressed either in the gut or in the CNS), and GM06434, the Drosophila homologue of the C. elegans gene nrf (nose resistant to fluoxetine). Both the transgene and the endogenous gene were successfully silenced in adult Drosophila by intra-abdominal injection of their respective dsRNA. We propose that our method of RNAi in adult flies can be used to characterize gene functioning in the CNS without the typical interference in development found in most gene mutation studies. Molecular Psychiatry (2001) 6, 665-670.
Introduction
RNA interference (RNAi) is a rapid method of specific gene inactivation. 1, 2 It is believed that RNAi is a physiological mechanism of functional gene silencing that is triggered by double-stranded RNA (dsRNA). This mechanism provides cells with a defense against mobile DNA elements that cause mutations or against viruses. According to the current understanding of this process, dsRNA is first processed into many short pieces, each of about 21-23 nucleotides. 3, 4 These fragments are incorporated into a complex which carries out the second RNA-degradation reaction. 5, 6 Whether RNAi could be considered a physiological process in the central nervous system (CNS) is a highly speculative proposition. 7 Experimentally, RNAi can be used to selectively suppress the endogenous RNA; ie, to functionally silence the corresponding gene. This approach was recently successfully applied in a functional analysis of two chromosomes, chromosome I and chromosome III of C. elegans. 8, 9 The feasibility of RNAi has been demonstrated in a variety of animal species, including C. elegans, flat-Drosophila is particularly interesting due to the recently completed sequencing of the Drosophila genome and because the fly provides an excellent model for studies of complex CNS functions and pathologies. 12 Although transgenic flies can be created to express dsRNA, 13, 14 a simple method of RNAimediated gene silencing in the CNS of adult flies, to circumvent the unwanted developmental effects of RNAi, would present a valuable new research tool.
In this report, we describe how intra-abdominal injection of dsRNA can be applied to induce RNAi and to silence two genes in adult Drosophila; the lacZ transgene (that encodes a protein with ␤-galactosidase activity) and the endogenous Drosophila gene GM06434, which is the Drosophila homologue of the gene originally found in C. elegans and termed nrf, nose resistant to fluoxetine. 15 In C. elegans, the Nrf gene family encodes putative transmembrane proteins, which are considered to be possible novel targets of antidepressant drugs.
Materials and methods

Fly stocks
The wild Canton-S (CS) strain was obtained from Ralph J Greenspan (The Neuroscience Institute, San Diego, CA, USA). Transgenic flies bearing the reporter lacZ construct that encompassed 11 kb intron of the pdp1 gene (restriction fragment) cloned into P-element pP(CaSpeR-AUG-bgal) reporter gene plasmid were from Robert V Storti (University of Illinois 
Injections
Flies were anesthetized by CO 2 (maximally for 5 min). We designed a vacuum-operated fly-holder to accurately position flies for intra-abdominal injection. In this holder, an elastic ring is used to fix a piece of paper tissue (Kimwipes EX-L) over the opening of a plastic tube (cut at an angle) attached to a vacuum pump. An additional side opening could be closed off by a fingertip to regulate the force of the vacuum holding the anesthetized fly on the surface of the paper. The holder is positioned over a porous surface attached to a humidified flow of CO 2 . The fly is positioned so that the abdomen can be approached with the injecting pipette. Using custom-beveled (World Precision Instruments) glass pipettes (20 × 40 m tip diameter) coupled to a cell injector (Narishige IM-200) and a micromanipulator (Narishige), we injected a volume of 0.2 l fly −1 by a pulse pressure of 300 kPa under a stereo microscope. Typically, the injection site was in the ventral mid-lateral part of the abdomen at the level between the 3rd and the 4th sternite.
RNAi induction
In our experiments, we used bacterial lacZ dsRNA, clone GM06434 dsRNA (GeneBank accession number AF173374), and as a control, dsRNA for the green fluorescent protein (GFP) gene. Three kb of the entire E. coli lacZ gene, the BamHI-XbaI fragment from the transformation vector pCaSpeR-AUG-bgal (which includes the homology with the Drosophila beta galactosidase gene; Table 1 ), the fragment between 128 and 652 nt from a partial cDNA of GM06434, or the 0.8 kb of the GFP gene were subcloned into the pBluescript IISK(±). T3 andT7 RNA polymerases were used to synthesize the RNA strands. Equal amounts of both sense and antisense strands were mixed together, heated to 85°C for 5 min, and cooled down slowly for 15 min. The quality of the dsRNA was assessed on 0.9% agarose gel. For the injections, dsRNA was diluted in injection buffer (0.1 mM sodium phosphate, pH 6.8; 5 mM KCl) in concentrations of 0.15-1.6 g l −1 (0.8 g l −1 in most experiments).
Detection of ␤-galactosidase enzyme activity ␤-galactosidase enzyme activity encoded by its structural gene lacZ was assayed in adult transgenic or wildtype flies as described elsewhere 16 with minor modifications. Flies were anesthetized with CO 2 and then rinsed with 95% ethanol and dissecting buffer (10 mM sodium phosphate, pH 7.2; 150 mM NaCl; 1 mM MgCl 2 ). Dissecting buffer (60 l) was spread on a siliconized slide. A scalpel was used to cut the fly along the anterior-posterior axis. Sectioning of the heads was performed on dry ice using a scalpel. The dissected flies were fixed with 1% glutaraldehyde/dissecting buffer, washed in dissecting buffer, and stained in XGal staining solution. The expression of lacZ was assessed by the presence of the blue reaction product.
Assay of lacZ and GM06434 mRNA contents
We used the RT-PCR assay and specific primers corresponding to the sequence of the bacterial lacZ (ie, the transformation vector used in transgenic flies): direct 5′-ctacgtctgaacgtcgaaaaccc-3′, reverse 5′-cacttcgatggtttgcccggata-3′, and GM06434: direct 5′-atcgatacggaactctttgcgt-3′, reverse 3′atttcgctggggatcac-taaac-5′. Total RNA was isolated from the dissected intestines of the transgenic flies (for lacZ) or from the bodies and the dissected CNS (for the CNS GM06434). The first strand synthesis was carried out for 1 h at 37°C. Thirty cycles of PCR were performed in 50 l of reaction mix at the following conditions: 92°C for 30 s, 57°C for 30 s, and 72°C for 45 s with 5 min of final elongation. An aliquot of the first strand reaction mix was used to amplify ribosomal gene RP49 mRNA with the following primers: direct, 5′-atgaccatccgcccagcataca-3′ and reverse, 5′-tgtgtattccgaccaggttac-3′.
Results
To test the feasibility of gene silencing in adult Drosophila via intra-abdominal dsRNA injection, we first developed a method for injecting anesthetized adult flies. This technique allows repeated injections of a volume of 0.2 l per fly without obvious injury; injected flies of both sexes not only survive for weeks, they also mate and generate colonies. We used this method to inject flies with 0.2 l of dsRNA-containing solution.
Previously, it was suggested that Drosophila expresses significant endogenous ␤-galactosidase activity, 17 and recent sequencing data point to a significant homology between the E. coli lacZ and the Drosophila melanogaster endogenous beta galactosidases (CG3132, CG9092; Genome Annotation Database of Drosophila) ( Table 1) . Thus, we selected our lacZ dsRNA to target the putative endogenous Drosophila lacZ as well as the transgenic bacterial lacZ. The transgenic lacZ was expressed either in the anterior and posterior midgut (11 kb intron Pdp1 transgenic flies), or in the CNS (we used two different enhancer trap fly lines).
The expression of the lacZ gene and the localization of its enzymatically active protein were assessed by the presence of a blue/green reaction developed during a standard X-Gal assay. We confirmed that significant endogenous ␤-galactosidase activity is present in the gut of wild-type flies (Figure 1a) . We also found that some of the X-Gal staining originated in the lumen of Table 1 Homology regions between E.coli and Drosophila ␤-galactosidase genes the gut in these flies, possibly due to lacZ expression in intestinal bacteria. Thus, a reduction but not complete abolishment of endogenous intestinal ␤-galactosidase activity was observed after feeding antibiotics to the flies (Figure 1b) . However, injection of lacZ dsRNA into naive adult wild-type flies completely removed the intestinal ␤-galactosidase activity assayed 72 h after injection (Figure 1c) .
One type of transgenic flies we used expresses lacZ and very strong ␤-galactosidase activity, both in the anterior and posterior midgut (Figure 1d ). Injection of lacZ dsRNA abolished enteric ␤-galactosidase activity in a time-dependent manner ( Table 2 ). We observed that higher concentrations of dsRNA (0.8-1.6 g l −1 ) were effective in abolishing the enteric X-gal staining earlier; ie, after 24 h, whereas lower concentrations (eg, 0.5 g l −1 ) were fully effective after 48 h (Table 2 ). Interestingly, the suppressing effect of lower concentrations appears to last longer (for 11 days at least), whereas 7 days after injection of higher concentrations of dsRNA we observed some X-gal staining ( Table 2 ).
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More than 24 h was needed for the RNAi process triggered by the concentration of 0.8 g l −1 lacZ dsRNA to reduce/abolish the transgenic lacZ mRNA content (Figure 1h ) and ␤-galactosidase activity (Figure 1e-g ). Injection of structurally unrelated dsRNA for the green fluorescent protein (GFP) gene did not reduce ␤-galactosidase activity (Figure 1d) .
We used two different types of transgenic flies that express ␤-galactosidase activity in the CNS (Figure 2a,b) and found that the inhibitory effect of lacZ dsRNA was not restricted to the enteric expression of the gene. Thus, although injected into the abdomen, lacZ dsRNA was effective in inhibiting ␤-galactosidase activity in the CNS of these lacZ transgenic flies (Figure 2c,d) .
Although the transgene lacZ is useful as a target to test whether RNAi injections in adults would be effective, the ultimate utility of the system depends on whether genes endogenous to Drosophila, particularly those expressed in the CNS, can be inhibited as well. To test this, we selected the endogenously expressed Figure 1 Endogenous and transgenic lacZ expression/␤-galactosidase activity in the gut of adult Drosophila and effect of injecting lacZ dsRNA. In control wild-type flies of both sexes, we detected ␤-galactosidase activity in the gut (indicated by the arrowhead (a)), and in the uterus, ejaculatory bulb and nephrocites (not shown). Because we hypothesized that some gut XGal staining might be due to the presence of intestinal bacteria, we attempted to reduce the presence of bacteria by feeding antibiotics to the flies (ampicillin 50 g ml −1 , tetracycline 30 g ml −1 , kanamycin 30 g ml −1 , chloramphenicol 30 g ml −1 , and amoxicillin 30 g ml −1 (500 l laid on top of the food)), for 2 days. Treatment with antibiotics reduced (b) whereas injection of lacZ dsRNA abolished (c) endogenous ␤-galactosidase activity. Transgenic reporter lacZ expression was evident in the anterior and posterior midgut of control flies injected with mock dsRNA (green fluorescent protein) (d) (a similar strong X-Gal reaction was observed in naive transgenic flies; not shown). Injection of lacZ dsRNA significantly reduced ␤-galactosidase activity 24 h after injection (e) and almost completely abolished it 48 h (f) and 72 h (g) after injection. The presence of the reporter lacZ mRNA was abolished 48 and 72 h after lacZ dsRNA injection whereas the level of RP49 mRNA was not affected (ctrl = naive transgenic control).
GM06434 mRNA. This gene product is abundant both in the CNS and in the periphery. The intra-abdominal injection of GM06434 dsRNA was effective in removing the endogenous GM06434 from both the CNS and the bodies of injected flies (Figure 3 ).
Discussion
Our results established for the first time that dsRNA injections into the abdominal body cavity of adult Drosophila could be used to trigger RNAi and to cause the consequent removal of the respective gene products from the adult organism, including from organs such as the CNS.
The two gene products we targeted in the CNS of adult flies were either a transgene (two lines of the bacterial lacZ-expressing flies) or the endogenous GM06434 mRNA. lacZ was used to demonstrate that RNAi could affect the phenotype in the adult CNS and not only the mRNA. Thus, the loss of function due to dsRNA injection was shown as the absence of the lacZencoded protein, ie, by the lack of ␤-galactosidase activity. On the other hand, GM06434 was used to demonstrate that the endogenous mRNA expressed in the CNS could also be removed by intra-abdominal injection of the corresponding dsRNA.
The functional role of GM06434 in Drosophila is not known and no mutants of this gene have been reported. GM06434 is homologous to members of the nrf family of genes identified in C. elegans. 15 These genes were discovered by screening mutant worms resistant to a neuromuscular behavioral effect of the antidepressant fluoxetine, ie, hypercontractions of the nose muscles. In C. elegans, nrf is expressed in the anterior hypo- The results are expressed as full activity (+), diminished activity (±), and absence of activity (−). The number of flies per group is indicated in parentheses; the extent of X-gal staining was consistent for each individual group, ie, no significant intra-group variability was observed; nd = not determined. dermis and in the intestine. Interestingly, Choy and Thomas 15 found that several other antidepressants require the presence of these genes to produce behavioral effects similar to those of fluoxetine in C. elegans. These genes encode predicted transmembrane proteins that are homologous both to each other and to the amino acid sequence of Drosophila GM06434-no other homology has been found as yet. It was proposed that these proteins might represent an alternative target Molecular Psychiatry ). The injected flies were processed 24 and 48 h after injection; the total RNA was extracted separately from the dissected CNS and the bodies (b) (20 flies per group). The presence of GM06434 mRNA (upper bands) was abolished in the CNS (24 h and 48 h) and the bodies (greatly reduced at 24 h; not detectable at 48 h) after GM06434 dsRNA injection (compared with controls injected with GFP dsRNA). RNAi did not affect the levels of RP49 mRNA (lower bands).
for antidepressants different from the known target, ie, serotonin transporters. 15 Our present finding, that RNAi can be used for silencing GM06434 in adult flies will help us develop a strategy for understanding the functional role of this gene. So far, we did not observe any major effects on the basal gross behavior of flies injected with GM06434 dsRNA (for example, photogeotaxy; data not shown). However, our current research will establish which fly phenotype is associated with this gene, and which behaviors in Drosophila are affected by administration of antidepressants.
Another endogenous gene, Drosophila lacZ, appears to be affected by dsRNA injection into adult flies. We suggest that, due to the homology between bacterial and Drosophila lacZ sequences, the dsRNA we used was not only effective against the transgene lacZ, but also in triggering RNAi both in bacteria (ie, antibioticsensitive ␤-galactosidase activity) and in Drosophila cells expressing endogenous lacZ. The functional role of Drosophila lacZ has not been extensively studied; so far, it has only been recognized that flies express significant endogenous ␤-galactosidase activity, 16 whereas recent sequencing data point to a significant homology between E. coli lacZ and Drosophila melanogaster endogenous beta galactosidases ( Table 1) . The lacZ dsRNA we used was primarily targeted against bacterial lacZ; ie, to silence the transgene. Nevertheless, we observed that it also suppressed endogenous lacZ; it appears that the homology between bacterial and Drosophila lacZ present in this 3-kb dsRNA is sufficient to trigger RNAi against both targets. This observation is not surprising since it has been demonstrated that RNAi can be triggered by RNA duplexes as short as 149 bp 18 or even 80 bp, 19 and the multiple regions of homology included in our 3000-bp dsRNA were at least that long. Moreover, long dsRNAs, such as the one used in our lacZ studies, could generate a greater variety of 21-23 nt RNAs than shorter dsRNAs, thereby increasing the chance for RNAi to occur. 19 Clearly, to use RNAi in a specific manner, the dsRNA has to be prepared to match only the selected target RNA because a sequence shared between several closely related genes may interfere with several members of the gene family. 20 In our experiments on ␤-galactosidase activity, we investigated the effect of increasing concentrations of dsRNA ranging from 0.15 to 1.6 g l −1 (0.08-0.9 M), and we injected volumes of 0.2 l fly −1 . Considering that the volume of a fly is about 2 l, the actual concentrations of lacZ dsRNA per fly were about 8-90 nM; ie, in the range of dsRNA concentrations found effective in silencing genes in Drosophila embryos. 19 We noticed that silencing of lacZ that was triggered with lower concentrations of the 3000 bp-long lacZ dsRNA lasted longer (at least 11 days) than silencing induced with higher dsRNA concentrations. On the other hand, the full effect of higher concentrations occurred faster than the full effect of lower concentrations. Although RNAi produces long-lasting gene silencing, it has been noticed that in some cases it also is reversible. 20 Numerous factors could influence the efficacy of RNAi in vivo; for example, the length of target mRNA, the length and concentration of dsRNA, the region of homology between the dsRNA and the target, as well as other lesser known mechanisms. 20 A better understanding of the exact mechanisms of RNAi will help us advance its use.
With recent successful efforts to fully sequence genomes of a variety of species including humans, RNAi emerges as a valuable tool to study loss-of-function phenotypes in functional genomics. With respect to the role of gene regulation in the functioning of a fully developed CNS, RNAi should ideally be used without causing CNS development disturbances. The simplicity of our RNAi technique can provide researchers with an accessible tool to study gene function in the CNS of adult fruit flies. Compared with the use of mutant flies, the advantage of this method is that a normal adult organism can be studied, ie, the targeted gene can be functionally silenced without interfering with the organism's development.
